Project Grant R01EB040985
- Federal Project Grant Award Summary The National Institute of Biomedical Imaging and Bioengineering (NIBIB) awarded Massachusetts General Hospital a $269,460 Project Grant effective August 1, 2025 through July 31, 2027 under the Discovery and Applied Research for Technological Innovations to Improve Human Health program (CFDA 93.286). The award supports the development of advanced magnetic resonance imaging (MRI) acquisition and analysis methods that combine diffusion-relaxometry...
- Federal Grant Award Summary Massachusetts Institute of Technology (MIT) received a $514,357 Project Grant award from the National Institute of Biomedical Imaging and Bioengineering under the Discovery and Applied Research for Technological Innovations to Improve Human Health program (CFDA 93.286). The award, dated June 1, 2025, with completion expected by May 31, 2029, supports the development and prototype demonstration of a portable, liquid-helium-free 1-Tesla/560-millimeter room-temperature...
- Federal Project Grant Award Summary Massachusetts General Hospital (The General Hospital Corporation) received a $199,616 Project Grant award from the National Institute of Biomedical Imaging and Bioengineering (NIBIB) under the Discovery and Applied Research for Technological Innovations to Improve Human Health program (CFDA 93.286), effective May 1, 2026 through April 30, 2028. The project develops a novel deep learning methodology for multi-modal biomedical data fusion that integrates three...
- Federal Grant Award Summary Brigham & Women's Hospital received a $3.16 million Project Grant from the National Cancer Institute under the Cancer Detection and Diagnosis Research Program (CFDA 93.394) awarded on August 14, 2025, with performance through July 31, 2029. The project develops and validates magnetic resonance fingerprinting (MRF) technology to non-invasively image glutamate metabolism in glioblastoma and other brain tumors. The research addresses a critical clinical need by...
- Federal Grant Award Summary The National Institute of Biomedical Imaging and Bioengineering (NIBIB) awarded Massachusetts General Hospital $656,750 through the Discovery and Applied Research for Technological Innovations to Improve Human Health program (CFDA 93.286) on August 1, 2025, for a three-year project period concluding July 31, 2028. The award funds research to develop and optimize Electrical Impedance Tomography (EIT) as a bedside imaging tool for assessing lung perfusion in acute...
- Federal Grant Award Summary Boston Children's Hospital received a $996,466 Project Grant from the National Institute of Biomedical Imaging and Bioengineering (NIBIB) under the Discovery and Applied Research for Technological Innovations to Improve Human Health program (CFDA 93.286), effective August 1, 2025 through May 31, 2029. The award supports the development and validation of motion- and distortion-robust quantitative magnetic resonance imaging (QMRI) technology designed to enhance...
- Federal Project Grant Award Summary The National Institute of Biomedical Imaging and Bioengineering (NIBIB) awarded Massachusetts General Hospital (MGH) a Project Grant totaling $206,250 on June 1, 2026, under the Discovery and Applied Research for Technological Innovations to Improve Human Health program (CFDA 93.286). The project, titled "Integrated Mechano-Arthroscope for Minimally Invasive Assessment of Joint Pathologies," aims to develop and validate a novel diagnostic device that...
- Federal Grant Award Summary Massachusetts General Hospital received a $165,000 Project Grant award from the National Institute of Biomedical Imaging and Bioengineering (NIBIB) under the Discovery and Applied Research for Technological Innovations to Improve Human Health program (CFDA 93.286) for a two-year project period beginning August 1, 2025 and concluding July 31, 2027. The award supports research focused on modeling and safety assessment of magnetic spinal cord stimulation (MSCS), an...
- Federal Grant Award Summary The National Institute of Biomedical Imaging and Bioengineering (NIBIB) awarded the University of Wisconsin-Madison a Project Grant totaling $2,375,411 under the Discovery and Applied Research for Technological Innovations to Improve Human Health program (CFDA 93.286). The award, effective August 1, 2025, with completion targeted for May 31, 2029, supports the design and development of magnetic resonance imaging (MRI) technologies intended to enhance clinical value...
- Federal Grant Award Summary New York University School of Medicine received a $672,087 Project Grant award dated August 12, 2025, from the National Institute of Biomedical Imaging and Bioengineering under the Discovery and Applied Research for Technological Innovations to Improve Human Health program (CFDA 93.286). The award supports development of artificial intelligence systems designed to optimize supplemental breast ultrasound screening for women with dense breast tissue. The project will...
The National Institute of Biomedical Imaging and Bioengineering (NIBIB) awarded Massachusetts General Hospital a Project Grant of $622,804 on June 2, 2026, under the Discovery and Applied Research for Technological Innovations to Improve Human Health program (CFDA 93.286). The grant supports the development of quantitative point-of-care magnetic resonance imaging (MRI) technology for breast cancer screening. The project addresses limitations of current screening modalities by proposing low-field MRI solutions to improve nationwide accessibility of breast cancer detection, particularly for populations with dense breast tissue and high-risk women who currently have limited access to supplemental imaging due to cost, contrast requirements, and scanner throughput constraints of conventional 1.5 Tesla and 3 Tesla systems. The research is scheduled for completion by March 31, 2030, and will be conducted at Massachusetts General Hospital's Research Management Division in Charlestown, Massachusetts. This initiative aligns with NIBIB's mission to advance biomedical imaging technologies that enhance disease detection and diagnosis, with the potential to improve early-stage breast cancer detection rates and patient outcomes through more accessible and efficient screening capabilities.Federal Grant Award Summary
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $622.8k | 6/3/26 |